Infographics

Could snake venom usher in a new era of band-aid?

Proteins in snake venom could support blood clotting at the site of injury.
Written byNathan Holwell
| 2 min read
A snake bares its fangs in front of a medicine bottle.

credit: James Rodrigues

Download the infographic here

Could snake venom usher in a new era of band-aid?
Illustrated by James Rodrigues

Big or small, in the kitchen or in an emergency room, flesh wounds and the subsequent bleeding need quick treatment to prevent infection and further complications. The body seals up wounds by creating a clot made of fibrin protein that prevents infection and further loss of blood. Commercial products such as Tisseel and Quikclot Combat Gauze can reduce the time to form a fibrin clot, but these can fail when a patient has impaired blood clotting, hypothermia, or blood that is more acidic than usual. Although usually harmful, snake venom may offer a surprising solution.

Snake venoms are complex mixtures of proteins that can affect a number of human systems, including the central nervous system, the muscular system, and the cardiovascular system. Some venoms are deadly because they create blood clots that circulate through the body as haemostatic clots, or prevent clots from forming at a wound, leading to fibrinolysis and excessive blood loss. In recent years, researchers harnessed the wound sealing properties of snake venom to form stable fibrin clots at the sites of injuries.

Reptilase, an enzyme made by pit vipers, rapidly creates fibrin when mixed with blood. When researchers mixed reptilase with a crosslinking agent, they created a bioadhesive that sticks to a wound and slowly releases reptilase to form a fibrin clot (1). The bioadhesive dramatically reduced the amount of blood lost and shortened the coagulation time compared to no treatment in animal models.

Another research group used two enzymes found in snake venom as a wound sealant. The first enzyme, ecarin, helps form blood clots. The second, textilinin, helps prevent the body from breaking down clots too quickly. Using mouse models and a hydrogel containing ecarin and textilinin, they found that the hydrogel slowed bleeding and reduced blood loss compared to untreated wounds. They also saw shortenend bleeding times and less blood loss in a mouse model of a bleeding disorder (2).

These types of bandages can be used in different environments to reduce bleeding times and blood loss. The researchers hope that using snake venom to help rather than hurt will usher in a new age of bandages.

References

  1. Guo Y. et al. Snake extract–laden hemostatic bioadhesive gel cross-linked by visible light. Sci Adv 7, eabf9635 (2021).
  2. Yegappan R. et al. Snake Venom Hydrogels as a Rapid Hemostatic Agent for Uncontrolled Bleeding. Adv Healthc Mater, 2200574 (2022).
Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

  • Nathan Holwell

    Nathan is a biomedical engineering PhD candidate at Queen's University whose research focuses on finding a way to repair ligaments by mimicking the biology and structure of the native tissue. As a science journalism intern, he is passionate about how complex scientific research can be shared with multiple audiences. When not writing or experimenting, he can be found perfecting his espresso making technique and playing with his two dogs.

    View Full Profile

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Abstract illustration of colorful spectral emission peaks.
As flow cytometry panels grow larger and more complex, thoughtful panel design has become critical for experimental success.
A scientist in a white lab coat looking into a microscope in a brightly lit modern laboratory.
Learn how developmental and reproductive toxicology study selection supports regulatory decision-making and generates meaningful nonclinical safety data.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.